Black Diamond Therapeutics, Inc. (BDTX)
NasdaqGS - NasdaqGS 延遲價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 5.11 |
| 開市 | 5.16 |
| 買盤 | 5.86 x 200 |
| 賣出價 | 5.90 x 300 |
| 今日波幅 | 5.16 - 5.95 |
| 52 週波幅 | 1.43 - 6.85 |
| 成交量 | |
| 平均成交量 | 650,025 |
| 市值 | 304.618M |
| Beta 值 (5 年，每月) | 2.64 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.88 |
| 業績公佈日 | 2024年5月07日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 12.80 |
ZacksBlack Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?
Black Diamond (BDTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksWall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 129.3% in Black Diamond (BDTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ZacksHow Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%
The mean of analysts' price targets for Black Diamond Therapeutics (BDTX) points to a 95.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
